Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects With Type 2 Diabetes
A legfontosabb adatok
- Ki végzi
- Federico II University
- Hol
- Naples (Olaszország)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 20 fő vett részt
- Kezdés
- 2024. máj. 3.
- Befejezés
- 2025. okt. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- Supplementation with Polyphenol Rich Drink
- Supplementation with Control Drink (Placebo)
- A regiszteradat frissítve
- 2026. november 12.
Ki vehet részt
- Életkor
- 35 év – 70 év
- Nem
- Csak férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 8 feltétel megnézéseKevesebb
Ki vehet részt
- Body Mass Index (BMI) >25 and ≤35 kg/m2
- Cholesterolemia ≤ 250 mg/dl and Triglyceridemia ≤ 200 mg/dl
- type 2 Diabetes in good glycemic control (Hb1Ac ≤7.5%) treated with diet alone or diet + metformin
Ki nem vehet részt
- Insulin therapy and other hypoglycemic drugs other than metformin
- Cardiovascular events (myocardial infarction and/or stroke)
- Renal insufficiency (serum creatinine >1.5 mg/dl) and liver failure (ALT/AST twice the normal values)
- Anemia (Hb <12 g/dl) or other chronic disease
- Habitual intense physical activity
Helyszínek itt: Olaszország
- Federico II UniversityNaples, Olaszország
A vizsgálatról
Mit akar kideríteni a vizsgálat
Nonalcoholic fatty liver disease (NAFLD) is a liver disease characterized by an abnormal accumulation of fat not due to alcohol or drug consumption that can evolve into steatohepatitis (NASH), fibrosis and cirrhosis. Its prevalence is high, affecting approximately 20-30% of the general adult population and is also growing in pediatric age. Obesity, insulin resistance and type 2 diabetes (T2DM) are common and well-known risk factors for NAFLD, which is approximately 2-3 times more prevalent among obese and diabetic individuals. Despite the high and increasing prevalence of NAFLD in the population, its pathophysiology is not fully understood and there is currently no pharmacological treatment available.
A teljes eredeti leírásKevesebb
Recent evidence suggests that dietary polyphenols may have specific beneficial effects on hepatic steatosis and associated sequelae by polyphenol metabolites and their phase II derivatives. Therefore, the aim of our study is to evaluate whether medium-term consumption of a beverage rich in polyphenols extracted from red grape pomace is able to exert beneficial effects on hepatic steatosis, cardiometabolic risk profile and microbiota composition of patients with type 2 diabetes.
A vizsgálat 2 csoportja
- Grape Pomace Polyphenol Rich DrinkA vizsgált kezelés
Participants consume an experimental drink rich in polyphenols extracted from red grape pomace (RGP) containing 1.5 g/150 ml of Gallic Acid Equivalent (GAE) polyphenols and 28 g/150 ml of soluble sugars (14 g of glucose and 14 g of fructose) during the lunch and dinner for 6 weeks
Kezelés: Supplementation with Polyphenol Rich Drink
- Placebo DrinkPlacebo, összehasonlításként
Participants consume a control drink (Placebo), containing zero polyphenol and 28 g of total sugars (14 g of glucose and 14 g of fructose solubilized in 150 ml of drinking water), quantities equivalent to those contained in the experimental drink, during the lunch and dinner for 6 weeks
Kezelés: Supplementation with Control Drink (Placebo)
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2026. november 12.